首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1738866

2026-2032 年微晶纖維素 (MCC) 市場（按原始材料類型、應用、最終用戶和地區分類）

Microcrystalline Cellulose Market By Source Type, Application, End User & Region for 2026-2032

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

微晶纖維素（MCC）市場評估，2026-2032

微晶纖維素 (MCC) 市場因其在各行各業（尤其是製藥、食品和化妝品）的廣泛應用而需求顯著成長。作為藥物製劑中的關鍵輔料，MCC 因其優異的黏合性、崩壞和流動性而備受推崇，這些特性能夠增強錠劑和膠囊的功效。隨著醫療支出增加和慢性病盛行率上升，全球製藥業的成長推動了對 MCC 的需求。預計 2024 年市場規模將超過 13.8 億美元，到 2032 年將達到約 24.6 億美元。

食品業正在將微晶纖維素 (MCC) 用作低熱量和無麩質產品中的脂肪替代品和穩定劑，進一步促進了市場的成長。對經濟高效情緒分析的需求日益成長，推動市場在 2026 年至 2032 年期間的複合年成長率達到 8.24%。

微晶纖維素（MCC）市場：定義/概述

微晶纖維素 (MCC) 是一種精製的、部分解聚合的纖維素，由植物纖維素水解而成。它呈白色無味粉末，具有高純度、低密度和優異流動性等獨特特性。 MCC 廣泛用於製藥、食品和化妝品行業，用作填充劑、粘合劑和穩定劑。在製藥業，它可作為錠劑賦形劑，提高可壓性並促進藥物釋放。在食品業，它可用作組織改質劑、脂肪替代品和填充劑，有助於提高各種產品的一致性和穩定性。

由於各行各業對天然和永續材料的需求日益成長，微晶纖維素被視為極具潛力的候選材料。隨著消費者對健康和營養意識的不斷提升，微晶纖維素在潔淨標示產品配方中的應用前景廣闊。奈米技術的創新或將推動基於微晶纖維素的奈米複合材料的開發，從而增強其在包裝和藥物傳輸系統等應用領域的功能性。生物技術的進步有望利用替代可再生資源生產微晶纖維素，進一步鞏固其作為環保原料的地位。隨著各行各業都在努力減少對環境的影響，微晶纖維素的生物分解性和可再生特性使其成為未來在健康、食品和材料科學領域應用的寶貴材料。

不斷發展的製藥業會推動微晶纖維素 (MCC) 市場的發展嗎？

蓬勃發展的製藥業將為微晶纖維素 (MCC) 市場提供強勁動力。製藥業是 MCC 的主要消費領域，將其用作各種藥物製劑的輔料。預計到 2026 年，全球藥品支出將達到 1.8 兆美元，複合年成長率為 3-6%。製藥業投資的不斷成長不僅推動了對 MCC 的需求（MCC 在提高錠劑可壓性、穩定性和生物有效性方面發揮著至關重要的作用），也凸顯了在開發新型創新藥物輸送系統時對高品質輔料的需求。

加工食品和簡便食品日益成長的需求是微晶纖維素 (MCC) 市場的主要驅動力。全球簡便食品市場正在迅速擴張，2021 年市場規模達 5,137 億美元，預計 2022 年至 2030 年的複合年成長率將達到 5.6%，因為消費者正在尋求快速易做的膳食選擇。 MCC 作為質構劑和脂肪替代品，使其成為一種有價值的添加劑，能夠改善加工食品的質地和穩定性，滿足消費者對更健康、低脂食品的偏好，同時又不影響產品品質。人們對簡便食品日益成長的偏好與 MCC 在食品配方中的使用量增加直接相關，從而推動了食品行業對這種用途廣泛的配料的整體需求。

原料的可用性會影響微晶纖維素 (MCC) 市場的成長嗎？

原料供應可能會阻礙微晶纖維素 (MCC) 市場的成長。 MCC 主要來自天然纖維素，例如木漿和植物纖維，但受氣候變遷、森林砍伐以及其他產業對這些原料的競爭等因素的影響，其供應量可能會出現波動。隨著生產商越來越注重環保的採購和生產方式，對永續實踐的需求不斷成長，這可能會對高品質纖維素的供應造成壓力。

由於食品和製藥業對添加劑的使用受到嚴格監管，監管障礙可能會阻礙微晶纖維素 (MCC) 市場的成長。這些法規通常要求進行廣泛的安全性和有效性評估，這可能會導致成本增加和產品核可時間延長。對於希望在全球銷售 MCC 的製造商而言，不同地區的不同監管標準構成了挑戰，使合規工作更加複雜。天然和潔淨標示產品的趨勢可能會促使監管機構調整其框架，以接納像 MCC 這樣安全有效的天然添加劑，從而提高其接受度並推動應用創新。

Wei Ming Pharmaceutical Co., Ltd.（China）
Juku Orchem Private Limited（India）
Sigachi（Japan）
BLANVER（China）
Anhui Sunhere Pharmaceutical Group Co., Ltd.（China）
Roquette Freres（France）
DuPont de Nemours, Inc.（US）
Ashland Global Holdings Inc.（US）
Borregaard ASA（Norway）
Imerys SA（France）

第11章市場展望與機會

新興技術
未來市場趨勢
投資機會

第12章附錄

簡稱列表
來源和參考文獻

簡介目錄

Product Code: 40706

Microcrystalline Cellulose Market Valuation - 2026-2032

The microcrystalline cellulose (MCC) market is experiencing a significant increase in demand due to its versatile applications across various industries, particularly in pharmaceuticals, food, and cosmetics. As a crucial excipient in drug formulations, MCC is valued for its excellent binding, disintegration, and flow properties, which enhance the efficacy of tablets and capsules. The growing global pharmaceutical industry, driven by an increase in healthcare spending and the rising prevalence of chronic diseases, is propelling the demand for MCC. The market size surpass USD 1.38 Billion valued in 2024 to reach a valuation of around USD 2.46 Billion by 2032.

The food industry is embracing MCC as a fat replacer and a stabilizer in low-calorie and gluten-free products, further contributing to its market growth. The rising demand for cost-effective and efficient emotion analytics is enabling the market grow at a CAGR of 8.24% from 2026 to 2032.

Microcrystalline Cellulose Market: Definition/ Overview

Microcrystalline cellulose (MCC) is a purified, partially depolymerized cellulose obtained from plant cellulose sources through hydrolysis. It appears as a white, odorless powder and possesses unique properties such as high purity, low density, and excellent flowability. MCC is widely utilized in the pharmaceutical, food, and cosmetic industries as a filler, binder, and stabilizer. In pharmaceuticals, it serves as an excipient in tablet formulations, enhancing compressibility and aiding in drug release. In the food industry, it acts as a texturizing agent, fat replacer, and bulking agent, contributing to the consistency and stability of various products.

Microcrystalline cellulose looks promising, driven by the growing demand for natural and sustainable ingredients in various sectors. With increasing consumer awareness regarding health and nutrition, MCC's applications are likely to expand in the formulation of clean-label products. Innovations in nanotechnology may lead to the development of MCC-based nanocomposites, enhancing their functionality in applications like packaging and drug delivery systems. Advancements in biotechnology may enable the production of MCC from alternative, renewable sources, further solidifying its role as an eco-friendly ingredient. As industries seek to minimize their environmental impact, MCC's biodegradable and renewable characteristics position it as a valuable material for future applications in health, food, and materials science.

Will the Growing Pharmaceutical Industry Drive the Microcrystalline Cellulose Market?

The growing pharmaceutical industry is set to significantly fuel the microcrystalline cellulose (MCC) market. As the pharmaceutical sector is a major consumer of MCC, utilizing it as an excipient in various drug formulations, the projected global spending on medicines-expected to reach $1.8 trillion by 2026 with a compound annual growth rate (CAGR) of 3-6%-indicates a robust growth trajectory for the industry. This increasing investment in pharmaceuticals not only drives demand for MCC due to its essential roles in enhancing tablet compressibility, stability, and bioavailability but also highlights the need for high-quality excipients in the development of new and innovative drug delivery systems.

The increasing demand for processed and convenience foods will significantly fuel the microcrystalline cellulose (MCC) market. As consumers seek quick, easy-to-prepare meal options, the global convenience food market, valued at $513.7 billion in 2021 and projected to grow at a CAGR of 5.6% from 2022 to 2030, is expanding rapidly. MCC's role as a texturizing agent and fat replacer makes it a valuable additive in enhancing the texture and stability of processed foods, catering to consumer preferences for healthier, lower-fat options without compromising on quality. This growing inclination towards convenience foods directly correlates with the increased utilization of MCC in food formulations, driving the overall demand for this versatile ingredient in the food industry.

Will Raw Material Availability Impact the Growth of the Microcrystalline Cellulose Market?

Raw material availability could potentially hamper the growth of the microcrystalline cellulose (MCC) market. MCC is primarily derived from natural cellulose sources, such as wood pulp and plant fibers, which are subject to fluctuations in availability due to factors like climate change, deforestation, and competition with other industries for these raw materials. The rising demand for sustainable practices may strain the supply of high-quality cellulose, as producers increasingly focus on eco-friendly sourcing and production methods.

Regulatory hurdles may hamper the growth of the microcrystalline cellulose (MCC) market, as the food and pharmaceutical industries are subject to stringent regulations regarding the use of additives. These regulations often require extensive safety and efficacy evaluations, which can lead to increased costs and extended timelines for product approvals. Varying regulatory standards across different regions can create challenges for manufacturers looking to market MCC globally, complicating compliance efforts, the trend towards natural and clean-label products may push regulatory bodies to adapt their frameworks to accommodate safe and effective natural additives like MCC, potentially facilitating its acceptance and encouraging innovation in its applications.

Category-Wise Acumens

Will High Purity and Consistency Propel the Non-Wood Based MCC Segment for the Microcrystalline Cellulose Market?

Non-Wood Based MCC Segment is dominating the microcrystalline cellulose market. High purity and consistency are key factors propelling the non-wood-based microcrystalline cellulose (MCC) segment in the microcrystalline cellulose market. As industries increasingly prioritize quality and safety, the demand for MCC with high purity levels becomes critical, especially in pharmaceuticals, food, and cosmetics, where contaminants can significantly impact product efficacy and consumer safety. Non-wood sources, such as cotton and certain plant fibers, offer a more consistent and controllable production process, resulting in a higher-quality end product. This consistency enhances the reliability of MCC in applications requiring precise formulations, thus driving growth in this segment.

Versatility is likely to propel the non-wood-based microcrystalline cellulose (MCC) segment in the microcrystalline cellulose market. This segment benefits from the ability to source MCC from various alternative raw materials, such as agricultural residues and non-wood plants, which can offer unique properties and functionalities tailored to specific applications in food, pharmaceuticals, and cosmetics. The growing demand for sustainable and eco-friendly products is driving manufacturers to seek alternatives to traditional wood-based sources, which are often associated with deforestation and environmental concerns.

Will Innovative Drug Development Boost the Pharmaceuticals Segment for the Microcrystalline Cellulose Market?

The pharmaceutical segment is dominating the microcrystalline cellulose market. Innovative drug development is expected to significantly promote the pharmaceuticals segment of the microcrystalline cellulose (MCC) market. As pharmaceutical companies pursue novel drug formulations and delivery systems, MCC's unique properties-such as its ability to enhance tablet disintegration, improve drug solubility, and act as a binding agent-make it a crucial excipient in formulation processes. The rise of personalized medicine and the need for more efficient drug delivery systems are driving demand for MCC, as it can be tailored to meet the specific requirements of various drug formulations.

The growing demand for pharmaceuticals will significantly promote the microcrystalline cellulose (MCC) segment within the microcrystalline cellulose market. MCC is widely used as an excipient in drug formulations due to its excellent binding, disintegrating, and flow properties, which enhance the efficiency and stability of pharmaceutical products. The increasing prevalence of chronic diseases and the subsequent rise in the need for effective medications are driving pharmaceutical companies to develop new formulations, thereby boosting the demand for high-quality excipients like MCC.

Country/Region-wise Acumens

Will the Increasing Pharmaceutical Industry Accelerate the North American Region for Microcrystalline Cellulose Market?

North America's dominance in the microcrystalline cellulose market. The growing pharmaceutical industry is set to accelerate the microcrystalline cellulose (MCC) market in North America. This region currently dominates the global MCC market, largely due to its strong pharmaceutical sector, which relies heavily on MCC as an excipient in drug formulations. The consistent increase in new drug approvals by the U.S. Food and Drug Administration (FDA)-with 59 in 2018, 48 in 2019, and 53 in 2020-highlights the expanding pharmaceutical landscape and directly drives the demand for MCC. The rising preference for processed foods in North America further contributes to the sustained growth of the MCC market, reinforcing the region's leadership in this industry.

The expansion of the food and beverage industry will accelerate the Microcrystalline Cellulose (MCC) market in North America. The U.S. Department of Agriculture (USDA) highlights that the food processing industry constitutes 16% of the nation's manufacturing sector value, indicating its substantial role in the economy. As consumers increasingly prioritize healthier and more convenient food options, the demand for MCC has surged, particularly as a fat replacer and stabilizer in low-fat products.

Will the Growing Food and Beverage Industry Lead the Asian Pacific Region for Microcrystalline Cellulose Market?

Asia Pacific is rapidly growing in the microcrystalline cellulose market. The growing food and beverage industry is expected to escalate the microcrystalline cellulose (MCC) market in the Asia Pacific region. According to the United Nations Food and Agriculture Organization (FAO), the region is projected to account for 39% of the global food market by 2030, highlighting its significance in the global food landscape. As health consciousness rises among Asian consumers, the demand for MCC as a stabilizer, texturizer, and fat replacer in low-calorie foods aligns perfectly with this trend.

The growing population in the Asia Pacific region will escalate the Microcrystalline Cellulose (MCC) market. The United Nations projects that Asia's population will rise to 5.2 billion by 2050, up from 4.7 billion in 2020, creating a substantial demand for food and pharmaceutical products. This population growth, combined with increasing disposable incomes, is expected to lead to higher consumption of processed foods and pharmaceuticals, where MCC is widely used as an excipient, binder, and stabilizer. As more consumers seek convenient and health-oriented products, the demand for MCC will continue to strengthen, driving market expansion in the region.

Competitive Landscape

The Microcrystalline Cellulose Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the market include:

FMC Corporation
DuPont de Nemours, Inc.,
Mingtai Chemical Co., Ltd.
Asahi Kasei Corporation
JRS Pharma
Sigachi Industries
BNF
Anhui Sunhere Pharmaceutical Excipients Co., Ltd.
HPMC
Medgel

Latest Developments

In December 2022, JRS PHARMA (J. RETTENMAIER & SOHNE GmbH + Co KG) revealed plans to build a new manufacturing plant in Cedar Rapids, Iowa. The facility, a two-story pre-cast building, will start construction in fall 2022 and begin operations in early 2024, producing Microcrystalline Cellulose products.
In September 2022, Roquette Freres S.A., a renowned global provider of plant-based ingredients and a top supplier of pharmaceutical and nutraceutical excipients, announced the full acquisition of Crest Cellulose, an excipient manufacturer based in India.